Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ji Gami injections for hair loss
NCT01451021Phase 2Completed
- Sponsor
- Aderans Research Institute
- Start
- Oct 2008
- Primary completion
- Jun 2010
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Ji Gami in androgenetic alopecia (AGA) (2 arms), sponsored by Aderans Research Institute. Primary endpoints: Change from baseline in hair number at 51 weeks, Change from baseline in hair width at 51 weeks and 1 more. Started Oct 2008; status: completed.
02
Drugs
Ji Gami
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT01451021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451021.